
doi: 10.1002/bio.4878
pmid: 39223925
AbstractBiofilm is a common problem associated with human health. Pathogenicity and increase in resistance of bacteria require urgent development of effective ways for the treatment of bacterial diseases. Different strategies have been developed for the treatment of bacterial infections among which nanoparticles have shown greater prospects in battling with infections. Biofilms are resistant microbial colonies that possess resistance and, hence, cannot be killed by conventional drugs. Nanoparticles offer new avenues for treating biofilm‐related infections involving multi‐drug resistant organisms. They possess great antibiofilm properties, disrupting cell architecture and preventing colony formation. Green‐synthesised nanoparticles are more effective and less toxic to human cells than commercially available or chemically synthesised antibiofilm nanoparticles. This review summarises the antibiofilm efficiency of plant‐mediated nanoparticles and knowledge about biofilm inhibition.
Bacteria, Biofilms, Nanoparticles, Humans, Microbial Sensitivity Tests, Anti-Bacterial Agents
Bacteria, Biofilms, Nanoparticles, Humans, Microbial Sensitivity Tests, Anti-Bacterial Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
